Does PATISIRAN Cause Muscular weakness? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Muscular weakness have been filed in association with PATISIRAN (Onpattro). This represents 1.4% of all adverse event reports for PATISIRAN.
37
Reports of Muscular weakness with PATISIRAN
1.4%
of all PATISIRAN reports
2
Deaths
18
Hospitalizations
How Dangerous Is Muscular weakness From PATISIRAN?
Of the 37 reports, 2 (5.4%) resulted in death, 18 (48.6%) required hospitalization, and 1 (2.7%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PATISIRAN. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does PATISIRAN Cause?
Death (250)
Product dose omission issue (175)
Fatigue (165)
Infusion related reaction (134)
Hospitalisation (127)
Asthenia (108)
Fall (107)
Intentional dose omission (107)
Cardiac failure (95)
Dyspnoea (87)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which PATISIRAN Alternatives Have Lower Muscular weakness Risk?
PATISIRAN vs PAXIL
PATISIRAN vs PAZOPANIB
PATISIRAN vs PEANUT
PATISIRAN vs PEG INTERFERON
PATISIRAN vs PEG-INTERFERON ALFA 2A